These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18243708)

  • 1. Intriguing nucleic-acid-binding features of mammalian prion protein.
    Silva JL; Lima LM; Foguel D; Cordeiro Y
    Trends Biochem Sci; 2008 Mar; 33(3):132-40. PubMed ID: 18243708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the interaction between prion protein and nucleic acid.
    Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
    Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.
    Gabus C; Auxilien S; Péchoux C; Dormont D; Swietnicki W; Morillas M; Surewicz W; Nandi P; Darlix JL
    J Mol Biol; 2001 Apr; 307(4):1011-21. PubMed ID: 11286552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein.
    Hachiya NS; Imagawa M; Kaneko K
    Med Hypotheses; 2007; 68(3):670-3. PubMed ID: 17008028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and analysis of prion dynamics in the presence of a chaperone.
    Kumar R; Murali P
    Math Biosci; 2008 May; 213(1):50-5. PubMed ID: 18362035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
    J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious nucleic acids in prion disease: halfway there.
    Radulescu RT; Brenig B
    Trends Biochem Sci; 2009 Jan; 34(1):4-5; author reply 5-6. PubMed ID: 18996016
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of RNA in mammalian prion protein conversion.
    Gomes MP; Vieira TC; Cordeiro Y; Silva JL
    Wiley Interdiscip Rev RNA; 2012; 3(3):415-28. PubMed ID: 22095764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
    Wang W; Chen R; Luo K; Wu D; Huang L; Huang T; Xiao G
    J Cell Biochem; 2010 Oct; 111(2):343-9. PubMed ID: 20506117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2009 Jun; 389(5):833-45. PubMed ID: 19393664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reconstitution of mammalian prion infectivity de novo.
    Baskakov IV
    FEBS J; 2007 Feb; 274(3):576-87. PubMed ID: 17288547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.
    Pérez DR; Damberger FF; Wüthrich K
    J Mol Biol; 2010 Jul; 400(2):121-8. PubMed ID: 20460128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.